There is virtually no protection against infection with the currently circulating omicron variant of the SARS-CoV-2 virus for dual-vaccinated and recovered individuals who were infected with the previous SARS-CoV-2 variants. ...
Feb 22, 2022
0
18
Preclinical models that recapitulate aspects of human airway disease are essential for the advancement of novel therapeutics and vaccines. In the current study published in the journal mBIO, researchers at Baylor College ...
Feb 15, 2022
0
131
U.S. health regulators on Friday authorized a new antibody drug that targets the omicron variant, a key step in restocking the nation's arsenal against the latest version of COVID-19.
Feb 11, 2022
0
5
Nearly four decades after its discovery, HIV has killed 36.3 million people, with no vaccine in sight. However, a new study by researchers at The Wistar Institute, an international biomedical research leader in cancer, immunology, ...
Feb 4, 2022
0
180
The drugs behind the new pills to treat COVID-19 remain very effective against the omicron variant of the virus in lab tests, according to a new study.
Jan 26, 2022
0
54
Yang Wang, MD, Ph.D., professor of medicine and deputy director of product discovery at MassBiologics of UMass Chan Medical School, leads a team of scientists working to discover and develop antibody-based medicines for infectious ...
Jan 24, 2022
0
17
Several, but not all, of the human monoclonal antibodies used clinically to prevent patients from becoming severely ill from COVID-19 may not be protective against the omicron variant now sweeping across the United States, ...
Jan 21, 2022
2
146
Researchers at UBC's faculty of medicine have conducted the world's first molecular-level structural analysis of the Omicron variant spike protein. The findings were published today in Science.
Jan 20, 2022
1
236
While the omicron variant continues to infect people around the world, researchers at the University of Missouri have identified the highly prevalent, specific mutations that are causing the omicron variant's high rate of ...
Jan 20, 2022
0
5
US biotech firm Regeneron said Tuesday that its synthetic antibody treatment for COVID-19 may be less effective against the new variant, and it plans to conduct tests to determine by how much.
Nov 30, 2021
0
4
